Canada's Ambrilia Biopharma says it will slash a third of its workforce as it cuts costs and lowers its burn rate. The move leaves Ambrilia with 29 employees--down from 43. The pink slips were primarily directed at the basic research and preclinical team and administrative support functions. Press release